Schedule 13G ownership disclosure

RXI PHARMACEUTICALS CORP

Security class unavailable · CUSIP: 74979C303

Event date: 2015-05-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.8600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-15-002712
Form type
SC 13G
Filer
Empery Asset Management, LP
CIK
CIK 1469336
Filed
Jun 01, 2015
Reporting period
May 27, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub